Comparative Effectiveness of Intervention in Multi-level Hospitals for Acute Traumatic Brain Injury(Metric-TBI)

NCT ID: NCT06429774

Last Updated: 2024-09-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

2000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-08-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A prospective, multicenter, observational cohort study is designed to compare the effectiveness of intervention in multi-grade hospitals for acute traumatic brain injury and to optimize clinical outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Traumatic brain injury (TBI) is associated with significant morbidity, mortality, and disability, profoundly impacting public health. This study aims to establish a database for acute craniocerebral trauma within the Beijing-Tianjin-Hebei region, and compiles indicators of hospital treatment capabilities and patient data, including neuroimaging, clinical progression, and rehabilitation prognoses.The study is bifurcated into two segments: the initial phase surveys the current status of acute treatment outcomes for TBI inpatients across hospitals in the Beijing-Tianjin-Hebei region and conducts a comparative effectiveness analysis to identify the clinical interventions to optimize. Subsequent phases build on the former by applying optimized treatment strategies to improve efficacy and establish collaborative optimized treatment protocols.

This is a prospective, multicenter, observational study designed to enroll 2,000 patients under the age of 90 years with traumatic brain injury in the presence of clinical symptoms confirmed by computed tomography or magnetic resonance imaging.The primary outcome is the Extended Glasgow Outcome Score within 12 months. Secondary outcomes include the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9(PHQ-9), Rivermead post-concussion symptoms questionnaire(RPQ), PTSD Checklist-5 Version(PCL-5),Six-Item Screener (SIS) and 12-Item Short-Form Health Survey version 2(SF-12v2).

The objective of this study is anticipated to the Beijing-Tianjin-Hebei region a 20 percent increase in the number of cases treated by optimized clinical practice guidelines and a 10 percent decrement in mortality and disability rates among TBI patients in the region.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Traumatic Brain Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TBI Group

TBI patients recruited from neurosurgical departments at 50 medical centers in China have apparent clinical symptoms that are confirmed by computed tomography or magnetic resonance imaging.

The exclusion criteria are those who fulfill one of the following conditions:

1. patients ≥90 years of age;
2. patients who did not accept follow-up visits or were unable to complete follow-up assessments;
3. patients with incomplete information;
4. patients who did not obtain written informed consent;
5. patients with concomitant cancer or other serious illnesses.

Neurological function

Intervention Type OTHER

Neurological function will be examined using Glasgow Coma Scale (GCS) and Extended Glasgow Outcome Scale (GOSE).The GOSE was created as an advancement from the original GOS. The GOSE score categorizes the prognosis of patients with traumatic brain injury into eight categories.The 8 categories are: Dead, Vegetative State, Lower Severe Disability, Upper Severe Disability, Lower Moderate Disability, Upper Moderate Disability, Lower Good Recovery, and Upper Good Recovery.

Mental State, cognitive function, and life quality assessment

Intervention Type OTHER

Mental State, cognitive function, and life quality will be examined using the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9(PHQ-9), Rivermead post-concussion symptoms questionnaire(RPQ), PTSD Checklist-5 Version(PCL-5),Six-Item Screener(SIS) and 12-Item Short-Form Health Survey version 2(SF-12v2).

Peripheral blood test

Intervention Type OTHER

Collect peripheral blood samples from patients.

Hematoma test

Intervention Type OTHER

Collect hematoma fluid, dura mater, and hematoma outer membrane samples from patients.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neurological function

Neurological function will be examined using Glasgow Coma Scale (GCS) and Extended Glasgow Outcome Scale (GOSE).The GOSE was created as an advancement from the original GOS. The GOSE score categorizes the prognosis of patients with traumatic brain injury into eight categories.The 8 categories are: Dead, Vegetative State, Lower Severe Disability, Upper Severe Disability, Lower Moderate Disability, Upper Moderate Disability, Lower Good Recovery, and Upper Good Recovery.

Intervention Type OTHER

Mental State, cognitive function, and life quality assessment

Mental State, cognitive function, and life quality will be examined using the Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9(PHQ-9), Rivermead post-concussion symptoms questionnaire(RPQ), PTSD Checklist-5 Version(PCL-5),Six-Item Screener(SIS) and 12-Item Short-Form Health Survey version 2(SF-12v2).

Intervention Type OTHER

Peripheral blood test

Collect peripheral blood samples from patients.

Intervention Type OTHER

Hematoma test

Collect hematoma fluid, dura mater, and hematoma outer membrane samples from patients.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient (1 years to 89 years) presenting with clinical symptoms of traumatic brain injury
* Traumatic brain injury verified on cranial computed tomography or magnetic resonance imaging
* Written informed consent from patients or their next of kin according to the patient's cognitive status

Exclusion Criteria

* patients ≥90 years of age
* patients who did not accept follow-up visits or were unable to complete follow-up assessments
* patients with incomplete information
* patients who did not obtain written informed consent
* patients with concomitant cancer or other serious illnesses
Minimum Eligible Age

1 Year

Maximum Eligible Age

89 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Beijing Tiantan Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Weiming Liu

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Weiming Liu, M.D.

Role: PRINCIPAL_INVESTIGATOR

Beijing Tiantan Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Beijing Fengtai You'anmen Hospital

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Beijing Huairou Hospital

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Beijing Luhe Hospital,Capital Medical University

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Beijing Red Cross Emergency Medical Center

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Beijing Tsinghua Changgung Hospital

Beijing, Beijing Municipality, China

Site Status RECRUITING

Peking University People's Hospital

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Beijing Chaoyang Hospital, Capital Medical University

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Beijing Chaoyang Integrative Medicine Rescue And First Aid Hospital

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Beijing Daxing District People's Hospital

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Peking University International Hospital

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Beijing Tiantan Hospital, Capital Medical University

Beijing, Beijing Municipality, China

Site Status RECRUITING

Beijing Changping Hospital

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Beijing Mentougou District Hospital

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Liangxiang Hospital

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

The First Hospital of Fangshan District, Bejing

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Dongfang Hospital of Beijing University of Chinese Medicine

Beijing, Beijing Municipality, China

Site Status NOT_YET_RECRUITING

Affiliated Hospital Of Hebei University

Baoding, Hebei, China

Site Status NOT_YET_RECRUITING

The No.2 Hospital of Baoding

Baoding, Hebei, China

Site Status NOT_YET_RECRUITING

Anguo Hospital

Baoding, Hebei, China

Site Status NOT_YET_RECRUITING

Rongcheng People's Hospital

Baoding, Hebei, China

Site Status NOT_YET_RECRUITING

Xiongxian Hospital

Baoding, Hebei, China

Site Status NOT_YET_RECRUITING

Baoding Seventh Hospital

Baoding, Hebei, China

Site Status NOT_YET_RECRUITING

Gaobeidian Hospital

Baoding, Hebei, China

Site Status RECRUITING

Yixian Hospital

Baoding, Hebei, China

Site Status NOT_YET_RECRUITING

Suning Hospital

Cangzhou, Hebei, China

Site Status NOT_YET_RECRUITING

Pingquan Hospital

Chengde, Hebei, China

Site Status NOT_YET_RECRUITING

Luanping Hospital

Chengde, Hebei, China

Site Status NOT_YET_RECRUITING

Hangang Hospital

Handan, Hebei, China

Site Status NOT_YET_RECRUITING

Weixian Chinese Traditional Medicine Hospital

Handan, Hebei, China

Site Status NOT_YET_RECRUITING

The No.1 Hospital Of Yongnian District Handan City

Handan, Hebei, China

Site Status NOT_YET_RECRUITING

Hebei Petro China Central Hospital

Langfang, Hebei, China

Site Status NOT_YET_RECRUITING

Langfang People's Hospital

Langfang, Hebei, China

Site Status RECRUITING

Edelburg Hospital

Langfang, Hebei, China

Site Status NOT_YET_RECRUITING

Sanhe Hospital

Langfang, Hebei, China

Site Status NOT_YET_RECRUITING

Yanjiao Fuhe No.1 Hospital

Langfang, Hebei, China

Site Status NOT_YET_RECRUITING

Dachang Hui Autonomous County People's Hospital

Langfang, Hebei, China

Site Status NOT_YET_RECRUITING

Xianghe Hospital

Langfang, Hebei, China

Site Status NOT_YET_RECRUITING

Fourth people's Hospital of Langfang

Langfang, Hebei, China

Site Status NOT_YET_RECRUITING

Dacheng Hospital

Langfang, Hebei, China

Site Status NOT_YET_RECRUITING

First Hospital of Qinhuangdao

Qinhuangdao, Hebei, China

Site Status NOT_YET_RECRUITING

Shanhaiguan People's Hospital

Qinhuangdao, Hebei, China

Site Status NOT_YET_RECRUITING

Qinhuangdao Funing District Hospital of Traditional Chinese Medicine

Qinhuangdao, Hebei, China

Site Status NOT_YET_RECRUITING

Lulong Hospital

Qinhuangdao, Hebei, China

Site Status NOT_YET_RECRUITING

Peking University Third Hospital Qinhuangdao Hospital

Qinhuangdao, Hebei, China

Site Status NOT_YET_RECRUITING

The Fourth Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

Site Status NOT_YET_RECRUITING

The Third Hospital Of Shijiazhuang

Shijiazhuang, Hebei, China

Site Status NOT_YET_RECRUITING

The Second Hospital of Hebei Medical University

Shijiazhuang, Hebei, China

Site Status NOT_YET_RECRUITING

Jingxing Hospital

Shijiazhuang, Hebei, China

Site Status NOT_YET_RECRUITING

Xinle Chinese Traditional Medicine Hospital

Shijiazhuang, Hebei, China

Site Status NOT_YET_RECRUITING

Tangshan Fengrun People's Hospital

Tangshan, Hebei, China

Site Status NOT_YET_RECRUITING

Tangshan Workers' Hospital

Tangshan, Hebei, China

Site Status NOT_YET_RECRUITING

Xingtai Central Hospital

Xingtai, Hebei, China

Site Status NOT_YET_RECRUITING

Xingtai People's Hospital

Xingtai, Hebei, China

Site Status NOT_YET_RECRUITING

Xingtai Xindu District People's Hospital

Xingtai, Hebei, China

Site Status NOT_YET_RECRUITING

Xingtai Nanhe District People's Hospital

Xingtai, Hebei, China

Site Status NOT_YET_RECRUITING

Pingxiang People's Hospital

Xingtai, Hebei, China

Site Status NOT_YET_RECRUITING

Wei County People's Hospital

Xingtai, Hebei, China

Site Status NOT_YET_RECRUITING

Qinghe Central Hospital

Xingtai, Hebei, China

Site Status NOT_YET_RECRUITING

Xingtai Ninth Hospital

Xingtai, Hebei, China

Site Status NOT_YET_RECRUITING

Tianjin First Central Hospital

Tianjin, Tianjin Municipality, China

Site Status NOT_YET_RECRUITING

Tianjin Hospital

Tianjin, Tianjin Municipality, China

Site Status NOT_YET_RECRUITING

Tianjin Fourth Central Hospital

Tianjin, Tianjin Municipality, China

Site Status NOT_YET_RECRUITING

Tianjin Xiqing Hospital

Tianjin, Tianjin Municipality, China

Site Status NOT_YET_RECRUITING

Wuqing People's Hospital

Tianjin, Tianjin Municipality, China

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Weiming Liu, M.D.

Role: CONTACT

13701182770

Yu Shi, M.D.

Role: CONTACT

13611533819

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Weiming Liu, MD

Role: primary

13701182770 ext. +86

Gesheng Wang, M.D.

Role: primary

+86 13581759316

References

Explore related publications, articles, or registry entries linked to this study.

Capizzi A, Woo J, Verduzco-Gutierrez M. Traumatic Brain Injury: An Overview of Epidemiology, Pathophysiology, and Medical Management. Med Clin North Am. 2020 Mar;104(2):213-238. doi: 10.1016/j.mcna.2019.11.001.

Reference Type BACKGROUND
PMID: 32035565 (View on PubMed)

Galgano M, Toshkezi G, Qiu X, Russell T, Chin L, Zhao LR. Traumatic Brain Injury: Current Treatment Strategies and Future Endeavors. Cell Transplant. 2017 Jul;26(7):1118-1130. doi: 10.1177/0963689717714102.

Reference Type BACKGROUND
PMID: 28933211 (View on PubMed)

Jiang JY, Gao GY, Feng JF, Mao Q, Chen LG, Yang XF, Liu JF, Wang YH, Qiu BH, Huang XJ. Traumatic brain injury in China. Lancet Neurol. 2019 Mar;18(3):286-295. doi: 10.1016/S1474-4422(18)30469-1. Epub 2019 Feb 12.

Reference Type BACKGROUND
PMID: 30784557 (View on PubMed)

Stocchetti N, Carbonara M, Citerio G, Ercole A, Skrifvars MB, Smielewski P, Zoerle T, Menon DK. Severe traumatic brain injury: targeted management in the intensive care unit. Lancet Neurol. 2017 Jun;16(6):452-464. doi: 10.1016/S1474-4422(17)30118-7.

Reference Type BACKGROUND
PMID: 28504109 (View on PubMed)

Steyerberg EW, Wiegers E, Sewalt C, Buki A, Citerio G, De Keyser V, Ercole A, Kunzmann K, Lanyon L, Lecky F, Lingsma H, Manley G, Nelson D, Peul W, Stocchetti N, von Steinbuchel N, Vande Vyvere T, Verheyden J, Wilson L, Maas AIR, Menon DK; CENTER-TBI Participants and Investigators. Case-mix, care pathways, and outcomes in patients with traumatic brain injury in CENTER-TBI: a European prospective, multicentre, longitudinal, cohort study. Lancet Neurol. 2019 Oct;18(10):923-934. doi: 10.1016/S1474-4422(19)30232-7.

Reference Type BACKGROUND
PMID: 31526754 (View on PubMed)

Silverberg ND, Duhaime AC, Iaccarino MA. Mild Traumatic Brain Injury in 2019-2020. JAMA. 2020 Jan 14;323(2):177-178. doi: 10.1001/jama.2019.18134. No abstract available.

Reference Type BACKGROUND
PMID: 31816030 (View on PubMed)

Sun D, Jiang B, Ru X, Sun H, Fu J, Wu S, Wang L, Wang L, Zhang M, Liu B, Wang W; for the NESS-China investigators. Prevalence and Altered Causes of Traumatic Brain Injury in China: A Nationwide Survey in 2013. Neuroepidemiology. 2020;54(2):106-113. doi: 10.1159/000501911. Epub 2019 Dec 18.

Reference Type BACKGROUND
PMID: 31851999 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SF 2024-1-2042

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.